• About Us
  • Brands in Conversation
    • Academic Connect
    • Marketing Trailblazers
  • Marketers in Conversation
    • Marketing Guru Speaks
  • Case Studies
  • Contact Us
    • Contribute Articles
    • Market Intelligence & Research
    • Skilling Programs
    • Internship
Search
Passionate In Marketing
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Friday, October 9, 2026
Sign in / Join
  • Home
  • Disclaimer
Facebook
Instagram
Linkedin
X
WhatsApp
Passionate In Marketing
  • About Us
  • Brands in Conversation
    • Academic Connect
    • Marketing Trailblazers
  • Marketers in Conversation
    • Marketing Guru Speaks
  • Case Studies
  • Contact Us
    • Contribute Articles
    • Market Intelligence & Research
    • Skilling Programs
    • Internship
Home Tags ADHD treatment

Tag: ADHD treatment

Granules Pharmaceuticals, Inc. Receives FDA Tentative Approval with 180-Day Exclusivity for Generic Amphetamine Extended-Release Tablets (gDYANAVEL XR)
Brands in Conversation

Granules Pharmaceuticals, Inc. Receives FDA Tentative Approval with 180-Day Exclusivity for Generic Amphetamine Extended-Release Tablets (gDYANAVEL XR)

Author -
January 9, 2026
0
Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)
Brands in Conversation

Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)

Author -
December 22, 2025
0
Glenmark Pharmaceuticals to Launch Mixed Salts of a Single Entity Amphetamine Tablets in Various Strengths
Brands in Conversation

Glenmark Pharmaceuticals to Launch Mixed Salts of a Single Entity Amphetamine Tablets in Various Strengths

Author -
April 17, 2025
0
Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules
Brands in Conversation

Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules

Passionate in Marketing -
January 30, 2025
0
Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.
Brands in Conversation

Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.

Passionate in Marketing -
December 17, 2024
0

EDITOR PICKS

Unitile Recognised Among India’s Best Workplaces for Women for the Second Consecutive Year

October 9, 2026

Imperial Blue Packaged Drinking Water adds an exciting new chapter to Because Men will be Men

October 9, 2026

GKB Unveils New Brand Identity with Sanya Malhotra as Brand Ambassador, marks 100th Store milestone

October 9, 2026

POPULAR POSTS

Shri Sudhanshu Ji Maharaj Inspires Manila and Hong Kong Gatherings with Message of Peace, Balance and Inner Harmony

October 6, 2026

NYAI Launches NYAI AI Studio: India’s First Agentic AI Infrastructure Platform for Legal and Compliance

October 5, 2026

Gracenote Redefines CTV Advertising with Content-First, Privacy-Safe Targeting

October 6, 2026

POPULAR CATEGORY

  • Brands in Conversation73661
  • Academic Connect1570
  • Marketers in Conversation1114
  • Collaborations & Partnerships592
  • Marketing Guru Speaks235
  • Marketing Trailblazers32
  • Articles18
  • Case Studies17
Passionate In Marketing

ABOUT US

Passionate in Marketing is promoted by i-miRa Knowledge Solutions, a company founded in 2010 to foster various business units dedicated to creating, disseminating, and managing knowledge-based products, services, and solutions. These offerings cater to corporate entities, startups, and academic institutions alike.

Contact : [email protected]

FOLLOW US

FacebookFacebook
InstagramInstagram
LinkedinLinkedin
XX
WhatsAppWhatsApp

© 2026 | Passionate In Marketing |All Rights Reserved | Privacy Policy

  • Home
  • Disclaimer